Evidence map›Paper›PMID 24522233›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2014

Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.

Xiaosai Yao, Atish D Choudhury, Yvonne J Yamanaka, Viktor A Adalsteinsson, Todd M Gierahn, Christina A Williamson, Carla R Lamb, Mary-Ellen Taplin, Mari Nakabayashi, Matthew S Chabot and 7 more

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis.Indian journal of clinical biochemistry : IJCB · 2019
    Review
  18. Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xiaosai YaoDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Atish D Choudhury
Yvonne J Yamanaka
Viktor A Adalsteinsson
Todd M Gierahn
Christina A Williamson
Carla R Lamb
Mary-Ellen Taplin
Mari Nakabayashi
Matthew S Chabot
Tiantian Li
Gwo-Shu M Lee
Jesse S Boehm
Philip W Kantoff
William C Hahn
K Dane Wittrup
J Christopher Love

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Physician Scientist Training in Cancer ResearchT32CA009172 · NCI · DANA-FARBER CANCER INSTITUTE · PI Jennifer R Brown, James A. DeCaprio · 1985 to 2026
$17.1M
NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051NCI NIH HHS T32 CA009172
6 · The paper itself

Abstract

Ample evidence supports genetic and functional heterogeneity in primary tumors, but it remains unclear whether circulating tumor cells (CTCs) also exhibit the same hierarchical organization. We examined the functional diversity of viable, single CTCs using an array of subnanoliter wells (nanowells). The compartmentalization of single cells by nanowells allowed clonal comparison and mapping of heterogeneity of single cells or preformed clusters of cells. By measuring the short-term viability, invasiveness and secretory profiles of individual CTCs, it was evident that only a rare subset of CTCs possessed malignant traits indicative of metastatic potential in late-stage, progressing metastatic castration-resistant prostate cancer (mCRPC) patients. These CTCs were resistant to anoikis after being in the circulation, were invasive in their epithelial state, or secreted proteases capable of cleaving peptide substrates. Every CTC observed, however, did not exhibit such metastatic potential, suggesting that enumeration of CTCs alone may be insufficient to understand metastasis or stratify patients.

Indexed as

AnoikisCell SurvivalFluorescence Resonance Energy TransferHumansMaleMicroscopy, FluorescenceNanotechnologyNeoplasm ProteinsNeoplasms, Hormone-DependentNeoplastic Cells, CirculatingProstatic NeoplasmsNeoplasm Proteins

Identifiers

PMID24522233
PMCPMC4369918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.